HYDROXYQUINOLINE SULFATE - search results

India - English - Central Drugs Standard Control Organization

entrozyme 30 tab

stadmed - iodochlorohydroxyquinoline - tab - 250mg - 30

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

indium (111in) oxinate curium 37 mbq/ml radiopharmac. precursor i.v. vial

curium belgium s.p.r.l.-b.v.b.a. - hydroxyquinoline 0,025 mg/ml; indium (111 in) oxine 37 mbq/ml - radiopharmaceutical precursor - 37 mbq/ml - indium (in-111) oxine 37 mbq/ml - indium (111in) oxinate labelled cells

United States - English - NLM (National Library of Medicine)

ammens medicated powder original- zinc oxide powder

idelle labs, ltd - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - zinc cation 9.1 g in 100 g - skin protectant powder dries the oozing and weeping of poison - ivy - oak - sumac - condition worsens - symptoms last more than 7 days or clear up and occur again within a few days

New Zealand - English - Medsafe (Medicines Safety Authority)

auralgan ear drops

haleon new zealand ulc - benzocaine 14 mg/ml; phenazone 54 mg/ml - ear drops - active: benzocaine 14 mg/ml phenazone 54 mg/ml excipient: glycerol hydroxyquinoline sulfate

United States - English - NLM (National Library of Medicine)

prastera- prasterone and ibuprofen kit

health science funding, llc - prasterone (unii: 459ag36t1b) (prasterone - unii:459ag36t1b) - prasterone 200 mg - oral prasterone (200mg per day) in female patients with active systemic lupus erythematosus (sle) has in several blinded, placebo-controlled randomized clinical studies been associated with a reduced risk of auto-immune flare, §§6.2, 14.1.1, a reduced risk of breast cancer and a reduced risk of death from any cause, §§6.4, 14.2. patients with sle may have depressed serum levels of 5-dehydroepiandrosterone sulfate (5-dheas). oral prasterone has been shown to restore sle patients' serum 5-dheas levels. prastera® oral softgels are intended for use in patients for whom medical evaluation shows a depressed serum level of dhea and thus a distinctive need for exogenous dhea. prastera® oral prasterone softgels are intended to be used under medical supervision, for a patient receiving active and ongoing medical supervision, wherein the patient obtains medical care on a recurring basis for, among other things, instructions on the use of this product. prastera® oral prasterone softgels are intended for the dietary m